tirzepatide and niacinamide / Injection Tirzepatide + Niacinamide: Clinical Rationale

I write perhaps three big essays per year

GLP3 Planner: Different approach

Anyone else have this happen before? The question resonated with many, prompting replies like: High protein levels in urine (also called proteinuria) are common in people with kidney disease and lupus nephritis

Slowed gastric emptying: One of the critical mechanisms of GLP-1 injections is their ability to slow down the emptying of the stomach

That data simply does not exist

The ADA 2025 presentations will cover: Phase 1 Trial Results for HM15275, Robust anti-obesity effect and mechanistic insights of HM15275 in animal models of obesity, Mechanistic insights into HM15275s improved quality of weight loss compared to tirzepatide (Zepbound), Weight loss and differentiated body composition improvement effects of HM17321, Glycemic control improvement observed with HM17321, and Synergistic effects on body composition improvement when combining HM15275 and HM17321 A large delegation from Hanmis R&D Center will attend ADA 2025 to present poster sessions showcasing the companys novel therapeutic approaches in obesity treatment and to explore potential collaborations with leading global pharmaceutical companies